Barr To Extend Branded Business Beyond Women's Health; Urology May Be Next
This article was originally published in The Pink Sheet Daily
Executive Summary
The company has two urology products in development but does not expect either to be approved before mid-2007. Barr is also considering expansion into rheumatology, dermatology, transplantation and vaccines.